DARE · Daré Bioscience, Inc.

Summary

Daré Bioscience completed a Regulation A offering, issuing 195,010 units at $5.00 each, comprising Series A Preferred Stock and warrants.

Key takeaways

• Closed offering of 195,010 units at $5.00 per unit, raising approximately $975,050.
• Each unit includes one share of Series A Convertible Preferred Stock and two warrants.
• Warrants allow purchase of up to 390,020 shares of common stock.
• Offering was conducted under Regulation A, qualified by SEC on April 1, 2026.
• Closings occurred on May 1, 4, 5, and 6, 2026.